Blepharitis surgery

Jump to navigation Jump to search

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis surgery On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis surgery

CDC on Blepharitis surgery

Blepharitis surgery in the news

Blogs on Blepharitis surgery

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Surgical intervention is not the first-line treatment option for patients with blepharitis. [1]

Surgery

Surgical intervention is usually reserved for the patients with complications of the blepharitis, such as chalasis, entropion, ectropion, or horizontal eyelid laxity. Surgical options in the treatment of MGD are generally limited to treatment of the complications of the disease, rather than the primary disease. MGD can be associated with pathologic conditions, such as conjunctivochalasis, entropion, ectropion, or horizontal eyelid laxity, which may be treated surgically, and treatment of these conditions can improve control of MGD.

Intraductal Meibomian Gland Probing

Invasive orifice penetration and intraductal probing seems to provide lasting rapid symptom relief for patients with posterior blepharitis with meibomian gland dysfunction (MGD).[2]

References

  1. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T; et al. (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction". Invest Ophthalmol Vis Sci. 52 (4): 2050–64. doi:10.1167/iovs.10-6997g. PMC 3072163. PMID 21450919.
  2. Maskin SL (2010). "Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction". Cornea. 29 (10): 1145–52. doi:10.1097/ICO.0b013e3181d836f3. PMID 20622668.

Template:WH Template:WS